Previous close | 514.00 |
Open | 518.40 |
Bid | 522.80 x 0 |
Ask | 523.20 x 0 |
Day's range | 517.80 - 526.20 |
52-week range | 308.60 - 599.40 |
Volume | |
Avg. volume | 210,057 |
Market cap | 37.717B |
Beta (5Y monthly) | 0.63 |
PE ratio (TTM) | 58.83 |
EPS (TTM) | 8.89 |
Earnings date | 25 Jul 2024 |
Forward dividend & yield | 4.00 (0.78%) |
Ex-dividend date | 13 May 2024 |
1y target est | 715.25 |
NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, today provides a business update.
Lonza Group ( VTX:LONN ) Full Year 2023 Results Key Financial Results Revenue: CHF6.72b (up 7.9% from FY 2022). Net...
Key Insights The considerable ownership by individual investors in Lonza Group indicates that they collectively have a...